Meropenem Fresenius Kabi 1 g inj./inf. sol. (pwdr.) i.v. vial

Land: Belgien

Sprache: Englisch

Quelle: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Wirkstoff:

Meropenem Trihydrate 1140 mg - Eq. Meropenem 1000,1 mg

Verfügbar ab:

Fresenius Kabi SA-NV

ATC-Code:

J01DH02

INN (Internationale Bezeichnung):

Meropenem Trihydrate

Dosierung:

1 g

Darreichungsform:

Powder for solution for injection/infusion

Zusammensetzung:

Meropenem Trihydrate 1140 mg

Verabreichungsweg:

Intravenous use

Therapiebereich:

Meropenem

Produktbesonderheiten:

CTI code: 374123-01 - Pack size: 1 g - Commercialisation status: NO - CNK code: 2834083 - Delivery mode: Medical prescription; CTI code: 374123-02 - Pack size: 10 x 1 g - Commercialisation status: NO - CNK code: 2825412 - Delivery mode: Medical prescription; CTI code: 374114-02 - Pack size: 10 x 1 g - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 374114-01 - Pack size: 1 g - Commercialisation status: NO - CNK code: 2834075 - Delivery mode: Medical prescription; CTI code: 374105-02 - Pack size: 10 x 1 g - Commercialisation status: YES - FMD code: 05425025650774 - CNK code: 2825412 - Delivery mode: Medical prescription; CTI code: 374105-01 - Pack size: 1 g - Commercialisation status: NO - CNK code: 2834067 - Delivery mode: Medical prescription

Berechtigungsstatus:

Commercialised: Yes

Berechtigungsdatum:

2010-07-27